Alena V. Lomonosova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alena V. Lomonosova has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Roman V. Polibin
Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Alla Ya. Mindlina
Sechenov University
3 shared publications - Alla Ya Mindlina
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow 119991, Russia
2 shared publications - Maksim O. Antipov
Sechenov University
2 shared publications - Nikolay I. Briko
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Vladimir A. Korshunov
Sechenov University
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 79-89
The relevance of modifying the vaccination strategy against Pertussis to protect infants in their first year of life
Relevance. Vaccination remains the most effective measure for controlling pertussis spread; however, immunization strategies may require revision in light of changing disease patterns. Aims . To identify current trends in pertussis incidence in the Russian Federation and propose modifications to vaccination strategies. Materials and methods . The study was based on analysis of statistical forms "Data on infectious and parasitic diseases" (Form No. 2) and "Data on populations of children and adults vaccinated against infectious diseases" (Form No. 6) for 2013–2025, as well as medical records of 535 infants who experienced pertussis during their first year of life in Moscow in 2023–2025. Results. Pertussis incidence in the Russian Federation demonstrates a sustained upward trend (average annual growth rate: 9.79 %), with infants under one year remaining the most vulnerable group, accompanied by an increase in pertussis-related mortality. Against this background, a substantial proportion of cases occurs among population groups most frequently serving as sources of infection for infants: during the study period, children aged 7–14 years accounted for 33–44 % of cases, while the share of adult cases increased (17 % nationally and 31 % in Moscow in 2025), substantiating the need for national implementation of age-targeted booster vaccination. The unfavorable epidemiological situation is exacerbated by delays in infant immunization (coverage < 50 % by the end of the first year of life) and low adherence to series completion among children following natural infection (among children who experienced pertussis in 2023, only 11.2 % continued immunization; in 2024 — 50.7 %; in 2025 — 7.6 %). Conclusions . To stabilize the situation, critical measures include: implementation of booster vaccination for school-aged children; mandatory maternal immunization to provide transplacental protection to newborns; and strict adherence to completion of vaccination series for children following pertussis infection.
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 79-89
Open AccessThe relevance of modifying the vaccination strategy against Pertussis to protect infants in their first year of life
Relevance. Vaccination remains the most effective measure for controlling pertussis spread; however, immunization strategies may require revision in light of changing disease patterns. Aims . To identify current trends in pertussis incidence in the Russian Federation and propose modifications to vaccination strategies. Materials and methods . The study was based on analysis of statistical forms "Data on infectious and parasitic diseases" (Form No. 2) and "Data on populations of children and adults vaccinated against infectious diseases" (Form No. 6) for 2013–2025, as well as medical records of 535 infants who experienced pertussis during their first year of life in Moscow in 2023–2025. Results. Pertussis incidence in the Russian Federation demonstrates a sustained upward trend (average annual growth rate: 9.79 %), with infants under one year remaining the most vulnerable group, accompanied by an increase in pertussis-related mortality. Against this background, a substantial proportion of cases occurs among population groups most frequently serving as sources of infection for infants: during the study period, children aged 7–14 years accounted for 33–44 % of cases, while the share of adult cases increased (17 % nationally and 31 % in Moscow in 2025), substantiating the need for national implementation of age-targeted booster vaccination. The unfavorable epidemiological situation is exacerbated by delays in infant immunization (coverage < 50 % by the end of the first year of life) and low adherence to series completion among children following natural infection (among children who experienced pertussis in 2023, only 11.2 % continued immunization; in 2024 — 50.7 %; in 2025 — 7.6 %). Conclusions . To stabilize the situation, critical measures include: implementation of booster vaccination for school-aged children; mandatory maternal immunization to provide transplacental protection to newborns; and strict adherence to completion of vaccination series for children following pertussis infection.
- Open Access
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 50-57
Analysis of Risk Factors in Patients with Bronchial Asthma: Genetic Markers and Comorbid Metabolic Disorders
Introduction . Bronchial asthma (BA) is a heterogeneous disease whose development involves not only genetic predisposition but also important non-hereditary factors, including comorbid conditions such as type 2 diabetes mellitus (T2DM) and metabolic syndrome. The shared pathogenetic mechanisms based on chronic inflammation suggest the existence of common genetic determinants, which remains understudied. Purpose. To identify molecular genetic markers and risk factors for predisposition to adult-onset BA associated with metabolic disorders. Materials and Methods . A retrospective case-control study was conducted on a sample of 315 individuals (63 BA patients and 252 conditionally healthy controls), matched for age and sex. Alongside the analysis of concomitant pathology, an association analysis was performed for polymorphisms in the genes: ADRB2 (rs1042713), IL6 (rs1800795), HLA-DQ2.5 (rs2187668), SLC30A8 (rs13266634), and TCF7L2 (rs12255372). Statistical analysis was performed using the χ² criterion in the StatTech v. 4.12.1 program (developer – StatTech LLC, Russia). Results . BA patients had a significantly higher prevalence of diabetes/metabolic syndrome-associated disorders (11.1 % vs. 4.0 %, p = 0.034) and diagnosed colitis (14.3 % vs. 3.6 %, p = 0.003). Strong associations with BA were found for polymorphisms in genes key to metabolism: SLC30A8 rs13266634 (C/C genotype: 41.3 % vs. 11.5 %, p < 0.001) and TCF7L2 rs12255372 (G/G genotype: 47.6 % vs. 14.3 %, p < 0.001). No associations were found for polymorphisms in the ADRB2, IL6, and HLA-DQ2.5 genes. Research limitations. The retrospective design and the relatively small sample size, which preclude establishing causal relationships. Conclusion . The obtained data indicate the existence of a "metabolically-associated" phenotype of adult-onset BA, whose pathogenesis is significantly linked to polymorphisms in the SLC30A8 and TCF7L2 genes and corresponding comorbidity. The results justify the expediency of mutual screening of BA patients for metabolic disorders and inflammatory bowel diseases.
- 3 August 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (3) , 50-57
Open AccessAnalysis of Risk Factors in Patients with Bronchial Asthma: Genetic Markers and Comorbid Metabolic Disorders
Introduction . Bronchial asthma (BA) is a heterogeneous disease whose development involves not only genetic predisposition but also important non-hereditary factors, including comorbid conditions such as type 2 diabetes mellitus (T2DM) and metabolic syndrome. The shared pathogenetic mechanisms based on chronic inflammation suggest the existence of common genetic determinants, which remains understudied. Purpose. To identify molecular genetic markers and risk factors for predisposition to adult-onset BA associated with metabolic disorders. Materials and Methods . A retrospective case-control study was conducted on a sample of 315 individuals (63 BA patients and 252 conditionally healthy controls), matched for age and sex. Alongside the analysis of concomitant pathology, an association analysis was performed for polymorphisms in the genes: ADRB2 (rs1042713), IL6 (rs1800795), HLA-DQ2.5 (rs2187668), SLC30A8 (rs13266634), and TCF7L2 (rs12255372). Statistical analysis was performed using the χ² criterion in the StatTech v. 4.12.1 program (developer – StatTech LLC, Russia). Results . BA patients had a significantly higher prevalence of diabetes/metabolic syndrome-associated disorders (11.1 % vs. 4.0 %, p = 0.034) and diagnosed colitis (14.3 % vs. 3.6 %, p = 0.003). Strong associations with BA were found for polymorphisms in genes key to metabolism: SLC30A8 rs13266634 (C/C genotype: 41.3 % vs. 11.5 %, p < 0.001) and TCF7L2 rs12255372 (G/G genotype: 47.6 % vs. 14.3 %, p < 0.001). No associations were found for polymorphisms in the ADRB2, IL6, and HLA-DQ2.5 genes. Research limitations. The retrospective design and the relatively small sample size, which preclude establishing causal relationships. Conclusion . The obtained data indicate the existence of a "metabolically-associated" phenotype of adult-onset BA, whose pathogenesis is significantly linked to polymorphisms in the SLC30A8 and TCF7L2 genes and corresponding comorbidity. The results justify the expediency of mutual screening of BA patients for metabolic disorders and inflammatory bowel diseases.
- Open Access
Impact of Vaccination on the Course and Outcome of COVID-19 in Patients with Multimorbidity
Vaccination is the most cost-effective method of preventing COVID-19; however, data on its effect on patients with multimorbidity is limited. The aim was to evaluate the effect of vaccination against new coronavirus infection (NCI) in patients with multimorbid pathology in hospital treatment on the outcome of COVID-19 disease. An analysis was carried out of 1832 records of patients in one of the COVID-19 hospitals in Moscow for 2020–2022. Statistical analysis was carried out using the StatTech v. 3.1.3 software, and the binary logistic regression (BLR) method was used to obtain prognostic models. The median age of patients was 69 years, and 76% of them had received two vaccine doses. To assess the outcome of the disease, two prognostic models were obtained depending on the presence of a multimorbidity in patients: cardiovascular pathology and/or atherosclerosis and/or type 2 diabetes mellitus (Model 1) or atherosclerosis and/or type 2 diabetes mellitus and/or encephalopathy (Model 2), against the background of the presence or absence of vaccination against NCI. When assessing the outcome of NCI in Model 1, the odds of death decreased by 3.228 times with two doses of Sputnik V in patients with multimorbidity. According to Model 2, for patients with multimorbidity, the chances of death decreased by 3.281 times with two doses of Sputnik V. The presence of two doses of Sputnik V increased the likelihood of recovery in patients with multimorbidity by more than three times.
Open AccessImpact of Vaccination on the Course and Outcome of COVID-19 in Patients with Multimorbidity
Vaccination is the most cost-effective method of preventing COVID-19; however, data on its effect on patients with multimorbidity is limited. The aim was to evaluate the effect of vaccination against new coronavirus infection (NCI) in patients with multimorbid pathology in hospital treatment on the outcome of COVID-19 disease. An analysis was carried out of 1832 records of patients in one of the COVID-19 hospitals in Moscow for 2020–2022. Statistical analysis was carried out using the StatTech v. 3.1.3 software, and the binary logistic regression (BLR) method was used to obtain prognostic models. The median age of patients was 69 years, and 76% of them had received two vaccine doses. To assess the outcome of the disease, two prognostic models were obtained depending on the presence of a multimorbidity in patients: cardiovascular pathology and/or atherosclerosis and/or type 2 diabetes mellitus (Model 1) or atherosclerosis and/or type 2 diabetes mellitus and/or encephalopathy (Model 2), against the background of the presence or absence of vaccination against NCI. When assessing the outcome of NCI in Model 1, the odds of death decreased by 3.228 times with two doses of Sputnik V in patients with multimorbidity. According to Model 2, for patients with multimorbidity, the chances of death decreased by 3.281 times with two doses of Sputnik V. The presence of two doses of Sputnik V increased the likelihood of recovery in patients with multimorbidity by more than three times.
- Open Access
- 1 July 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 22 (3) , 57-63
Analysis of Molecular Genetic Markers of Osteoporosis in Residents of the Russian Federation
Relevance. Osteoporosis is a multifactorial disease with a high level of disability, which is a serious health problem worldwide. High prevalence and disability rates are associated not only with the peculiarities of the course of this pathology, but also with the untimely diagnosis and initiation of therapy. Therefore, it is extremely relevant to search for specific and accessible markers of osteoporosis, such as molecular genetic markers or single-nucleotide polymorphisms, analysis of which will help identify risk factors for disease development before clinical symptoms manifest during patient examinations.Aims. This study is aimed at finding risk factors for the development of HCG in patients with gastritis and the relationship of polymorphisms of various genes with the development of this pathology.Materials and methods. A search was made for the association with osteoporosis of singlenucleotide polymorphisms of the genes: COL1A1, CYP2R1, ESR1, LCT, LRP5, VDR in residents of the Russian Federation (n = 669). Polymorphic markers of candidate genes were selected for research based on the presence of associations with osteoporosis according to previously conducted studies published in the RSCI, PubMed, Web of Science, MEDLINE, Scopus databases, as well as on the results of monitoring polymorphisms included in the panels of genetic predisposition to osteoporosis of companies engaged in genetic testing in the Russian Federation. Two groups were formed for the study: the main (case) – 234 patients with an established diagnosis of Osteoporosis, the control – 435 patients selected using a random number generator from conditionally healthy individuals from the Basis Genomic Group database (Basis Genomics LLC). The groups were comparable in age and gender (p > 0.05).Statistical analysis was carried out using the StatTech v. 3.1.6. program (developed by Stattech LLC, Russia). The nature of the distribution of quantitative data was checked by the Shapiro-Wilk, Kolmogorov-Smirnov criteria, the statistical significance of differences in 2 independent groups was assessed using the Mann-Whitney U-test. The ꭓ2 Pearson criterion was used to evaluate the associations of alleles of selected genes with the risk of osteoporosis.Results and discussions. Analysis of the maps of 669 patients showed that for residents of the Russian Federation, the polymorphism rs3736228 of the LRP5 gene can be used as a genetic marker of osteoporosis, since there were significant differences in the frequency of occurrence of CT and TT allele variants in the group of patients with osteoporosis and in the control group. Results of studies of single-nucleotide polymorphisms COL1A1_rs1800012_G/T, CYP2R1_rs10741657_A/G, ESR1_rs2234693_C/T, ESR1_rs9340799_A/G, LCT_rs4988235_C/T, VDR_rs1544410_A/G, VDR_rs2228570_C/T in residents of the Russian Federation The federations did not show significant differences between the groups, therefore, in the future, the results of studies of these polymorphisms to assess the risk of osteoporosis in patients should be evaluated with caution.Conclusions. According to the results of the study conducted on residents of the Russian Federation, only one of the eight alleles in candidate genes for the risk of osteoporosis showed a significant relationship in patients in the Russian Federation. It has been shown that variants of TT and CT polymorphism rs3736228 of the LRP5 gene are the risk genotype for osteoporosis.
- 1 July 2023
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 22 (3) , 57-63
Open AccessAnalysis of Molecular Genetic Markers of Osteoporosis in Residents of the Russian Federation
Relevance. Osteoporosis is a multifactorial disease with a high level of disability, which is a serious health problem worldwide. High prevalence and disability rates are associated not only with the peculiarities of the course of this pathology, but also with the untimely diagnosis and initiation of therapy. Therefore, it is extremely relevant to search for specific and accessible markers of osteoporosis, such as molecular genetic markers or single-nucleotide polymorphisms, analysis of which will help identify risk factors for disease development before clinical symptoms manifest during patient examinations.Aims. This study is aimed at finding risk factors for the development of HCG in patients with gastritis and the relationship of polymorphisms of various genes with the development of this pathology.Materials and methods. A search was made for the association with osteoporosis of singlenucleotide polymorphisms of the genes: COL1A1, CYP2R1, ESR1, LCT, LRP5, VDR in residents of the Russian Federation (n = 669). Polymorphic markers of candidate genes were selected for research based on the presence of associations with osteoporosis according to previously conducted studies published in the RSCI, PubMed, Web of Science, MEDLINE, Scopus databases, as well as on the results of monitoring polymorphisms included in the panels of genetic predisposition to osteoporosis of companies engaged in genetic testing in the Russian Federation. Two groups were formed for the study: the main (case) – 234 patients with an established diagnosis of Osteoporosis, the control – 435 patients selected using a random number generator from conditionally healthy individuals from the Basis Genomic Group database (Basis Genomics LLC). The groups were comparable in age and gender (p > 0.05).Statistical analysis was carried out using the StatTech v. 3.1.6. program (developed by Stattech LLC, Russia). The nature of the distribution of quantitative data was checked by the Shapiro-Wilk, Kolmogorov-Smirnov criteria, the statistical significance of differences in 2 independent groups was assessed using the Mann-Whitney U-test. The ꭓ2 Pearson criterion was used to evaluate the associations of alleles of selected genes with the risk of osteoporosis.Results and discussions. Analysis of the maps of 669 patients showed that for residents of the Russian Federation, the polymorphism rs3736228 of the LRP5 gene can be used as a genetic marker of osteoporosis, since there were significant differences in the frequency of occurrence of CT and TT allele variants in the group of patients with osteoporosis and in the control group. Results of studies of single-nucleotide polymorphisms COL1A1_rs1800012_G/T, CYP2R1_rs10741657_A/G, ESR1_rs2234693_C/T, ESR1_rs9340799_A/G, LCT_rs4988235_C/T, VDR_rs1544410_A/G, VDR_rs2228570_C/T in residents of the Russian Federation The federations did not show significant differences between the groups, therefore, in the future, the results of studies of these polymorphisms to assess the risk of osteoporosis in patients should be evaluated with caution.Conclusions. According to the results of the study conducted on residents of the Russian Federation, only one of the eight alleles in candidate genes for the risk of osteoporosis showed a significant relationship in patients in the Russian Federation. It has been shown that variants of TT and CT polymorphism rs3736228 of the LRP5 gene are the risk genotype for osteoporosis.
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (4)
The role of the student scientific circle in the formation of graduates of a new format – physicians researchers
Роль студенческого научного кружка в формировании выпускников нового формата - врачей-исследователей
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (4)
Open AccessThe role of the student scientific circle in the formation of graduates of a new format – physicians researchers
Роль студенческого научного кружка в формировании выпускников нового формата - врачей-исследователей
- Open Access
- 31 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (7) , 4136
Healthcare Workers’ Acceptance of COVID-19 Vaccination in Russia
During the COVID-19 pandemic, the problem of the population’s adherence to vaccination has become significantly aggravated around the world. This study is aimed at evaluating healthcare workers’ (HCWs) acceptance of COVID-19 vaccination in Russia. A cross-sectional multicenter study was carried out by interviewing HCWs in Russia using an electronic questionnaire and snowball sampling. The analysis included 85,216 questionnaires from 81 out of 85 regions of Russia. Statistical analysis was performed using SPSS v.22. The results indicated that 35.0% (CI 95%, 34.7–35.3) of HCWs were ready to get COVID-19 vaccination. The acceptance level was 42.4% (41.8–42.9) for all physicians and 31.3% (30.9–31.6) for nursing staff. A total of 29.4% (29.1–29.7) of HCWs were willing to recommend COVID-19 vaccination to patients: 38.5% (38.0–39.1) of physicians, and 24.7% (24.4–25.1) of nursing staff. Acceptance of COVID-19 vaccination is higher among HCWs dealing with infectious diseases and involved in vaccination. The low acceptance of HCWs toward vaccination against COVID-19 can be explained by the low level of awareness of HCWs in these issues. Additional educational programs are needed for HCWs, both for physicians and nurses, using all possible forms and methods of education.
- 31 March 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (7) , 4136
Open AccessHealthcare Workers’ Acceptance of COVID-19 Vaccination in Russia
During the COVID-19 pandemic, the problem of the population’s adherence to vaccination has become significantly aggravated around the world. This study is aimed at evaluating healthcare workers’ (HCWs) acceptance of COVID-19 vaccination in Russia. A cross-sectional multicenter study was carried out by interviewing HCWs in Russia using an electronic questionnaire and snowball sampling. The analysis included 85,216 questionnaires from 81 out of 85 regions of Russia. Statistical analysis was performed using SPSS v.22. The results indicated that 35.0% (CI 95%, 34.7–35.3) of HCWs were ready to get COVID-19 vaccination. The acceptance level was 42.4% (41.8–42.9) for all physicians and 31.3% (30.9–31.6) for nursing staff. A total of 29.4% (29.1–29.7) of HCWs were willing to recommend COVID-19 vaccination to patients: 38.5% (38.0–39.1) of physicians, and 24.7% (24.4–25.1) of nursing staff. Acceptance of COVID-19 vaccination is higher among HCWs dealing with infectious diseases and involved in vaccination. The low acceptance of HCWs toward vaccination against COVID-19 can be explained by the low level of awareness of HCWs in these issues. Additional educational programs are needed for HCWs, both for physicians and nurses, using all possible forms and methods of education.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (1)
To the 90th anniversary of the Department of Epidemiology and Evidence-based Medicine of the Sechenov University: from history to the present
Статья посвящена 90-летнему юбилею кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф.Ф. Эрисмана Первого МГМУ им. И.М. Сеченова. Выделены основные этапы в развитии кафедры. Показано, что на протяжении всей истории кафедра являлась головной в определении методологии преподавания эпидемиологии, играла ведущую роль в становлении эпидемиологии как науки, ее структуры и содержания. За последние годы в работе кафедры осуществлен ряд серьезных преобразований, направленных на внедрение в образовательный процесс новых технологий и последних достижений в области преподавания эпидемиологии. Сегодня сотрудники кафедры оперируют новейшими данными доказательной медицины, преподают дисциплину, опираясь на современные стандарты. Обучение студентов, специалистов в ординатуре и научных кадров в аспирантуре проводится согласно утвержденной рабочей программе, на основе современных учебно-методических материалов и интерактивных технологий. Период пандемии новой коронавирусной инфекции способствовал стремительному развитию телекоммуникационных возможностей и онлайн-образования. Активно работают научный кружок и школа мастерства «Эпидемиолог будущего», реализуется студенческий волонтерский проект «Авангард профилактики», направленные на подготовку специалистов, владеющих современными технологиями профилактической медицины. Коллектив кафедры активно участвует в научных проектах ИОЗ им. Эрисмана, результаты научных исследований публикуются в отечественных и зарубежных изданиях.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (1)
To the 90th anniversary of the Department of Epidemiology and Evidence-based Medicine of the Sechenov University: from history to the present
Статья посвящена 90-летнему юбилею кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф.Ф. Эрисмана Первого МГМУ им. И.М. Сеченова. Выделены основные этапы в развитии кафедры. Показано, что на протяжении всей истории кафедра являлась головной в определении методологии преподавания эпидемиологии, играла ведущую роль в становлении эпидемиологии как науки, ее структуры и содержания. За последние годы в работе кафедры осуществлен ряд серьезных преобразований, направленных на внедрение в образовательный процесс новых технологий и последних достижений в области преподавания эпидемиологии. Сегодня сотрудники кафедры оперируют новейшими данными доказательной медицины, преподают дисциплину, опираясь на современные стандарты. Обучение студентов, специалистов в ординатуре и научных кадров в аспирантуре проводится согласно утвержденной рабочей программе, на основе современных учебно-методических материалов и интерактивных технологий. Период пандемии новой коронавирусной инфекции способствовал стремительному развитию телекоммуникационных возможностей и онлайн-образования. Активно работают научный кружок и школа мастерства «Эпидемиолог будущего», реализуется студенческий волонтерский проект «Авангард профилактики», направленные на подготовку специалистов, владеющих современными технологиями профилактической медицины. Коллектив кафедры активно участвует в научных проектах ИОЗ им. Эрисмана, результаты научных исследований публикуются в отечественных и зарубежных изданиях.
- Open Access
- 5 November 2021
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 20 (5) , 4-20
Modeling of the Potential Effect of Revaccination against Whooping Cough in Children Aged 6–7 and 14 years within the Framework of the National of preventive vaccinations
Relevance. Currently, the national calendar of preventive vaccinations does not provide for revaccination against whooping cough in children over the age of 18 months. At the same time, the epidemiological and economic feasibility of revaccination against whooping cough in children aged 6–7 years, as well as adolescents, has been demonstrated in world practice. Aim. Based on a mathematical model, develop a forecast of pertussis morbidity dynamics and assess the potential socio-economic damage under the current and expanded vaccine prophylaxis algorithms.Methods. Mathematical modeling of the potential effect of revaccination against whooping cough in children aged 6–7 years (scenario 1) and at 6–7 years and 14 years (scenario 2) was carried out within the framework of the national calendar of preventive vaccinations. A simulation dynamic mathematical model is constructed that allows predicting the development of the epidemiological process of whooping cough on the basis of the dynamics of the main indicators of its prevalence in the population that developed in previous years. The model took into account dynamic changes in the preventive effectiveness of vaccinations and the potential level of underestimation of morbidity. The obtained arrays of indicators served as the basis for extrapolating trends in morbidity and mortality until 2034.The calculation of epidemiological benefits was carried out in the metrics of prevented loss of years of life under the two scenarios under consideration in comparison with the current vaccination algorithm. The calculation of the economic effect was carried out on the basis of the obtained indicators of epidemiological benefits in the metrics of the monetary equivalent of the average cost of a year of life, taking into account the projected inflation coefficients until 2034.Results. The projected decrease in the number of years of life lived in a state of illness, in comparison with the current situation, will total 44.5 thousand years for the period 2019–2034 under scenario 1 and 66.7 thousand years under scenario 2. The socio-economic damage from prevented cases of the disease, expressed in the monetary equivalent of the average cost of living, will decrease by 28.6% (scenario 1) or 42.0% (scenario 2).Conclusions. A comparison of the received public benefits with the costs of vaccination shows that the expansion of the NCPP with additional revaccinations against whooping cough (at 6–7 years or at 6–7 and at 14 years) is advisable both in epidemiological and economic aspects.
- 5 November 2021
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 20 (5) , 4-20
Open AccessModeling of the Potential Effect of Revaccination against Whooping Cough in Children Aged 6–7 and 14 years within the Framework of the National of preventive vaccinations
Relevance. Currently, the national calendar of preventive vaccinations does not provide for revaccination against whooping cough in children over the age of 18 months. At the same time, the epidemiological and economic feasibility of revaccination against whooping cough in children aged 6–7 years, as well as adolescents, has been demonstrated in world practice. Aim. Based on a mathematical model, develop a forecast of pertussis morbidity dynamics and assess the potential socio-economic damage under the current and expanded vaccine prophylaxis algorithms.Methods. Mathematical modeling of the potential effect of revaccination against whooping cough in children aged 6–7 years (scenario 1) and at 6–7 years and 14 years (scenario 2) was carried out within the framework of the national calendar of preventive vaccinations. A simulation dynamic mathematical model is constructed that allows predicting the development of the epidemiological process of whooping cough on the basis of the dynamics of the main indicators of its prevalence in the population that developed in previous years. The model took into account dynamic changes in the preventive effectiveness of vaccinations and the potential level of underestimation of morbidity. The obtained arrays of indicators served as the basis for extrapolating trends in morbidity and mortality until 2034.The calculation of epidemiological benefits was carried out in the metrics of prevented loss of years of life under the two scenarios under consideration in comparison with the current vaccination algorithm. The calculation of the economic effect was carried out on the basis of the obtained indicators of epidemiological benefits in the metrics of the monetary equivalent of the average cost of a year of life, taking into account the projected inflation coefficients until 2034.Results. The projected decrease in the number of years of life lived in a state of illness, in comparison with the current situation, will total 44.5 thousand years for the period 2019–2034 under scenario 1 and 66.7 thousand years under scenario 2. The socio-economic damage from prevented cases of the disease, expressed in the monetary equivalent of the average cost of living, will decrease by 28.6% (scenario 1) or 42.0% (scenario 2).Conclusions. A comparison of the received public benefits with the costs of vaccination shows that the expansion of the NCPP with additional revaccinations against whooping cough (at 6–7 years or at 6–7 and at 14 years) is advisable both in epidemiological and economic aspects.
- Open Access
- 4 November 2020
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 97 (5) , 492-502
Causes and consequences of delayed vaccination against pertussis infection in the Russian Federation
Introduction. One of the reasons for the increase of pertussis in the Russian Federation on the background of the widespread coverage of prophylactic vaccinations of more than 95% is a large number of unreasonable medical recusals and parental refusals and, as a result, untimely prophylactic vaccinations against pertussis infection.Materials and methods. We analyzed 5101 emergency notifications for pertussis in children under 17 years of age in Moscow in 2012-2017 and 300 child development histories for children under 14 years of age in two clinics in Moscow. A сase-сontrol study was conducted to assess the relationship between pertussis and the presence of deviations in the immunization schedule.Results. It was found that the level of timely immunization against pertussis did not exceed 5%. Medical (20%) and parental refusals (45%) prevail among the reasons for delayed vaccination. In the structure of medical exemption, the main causes are perinatal encephalopathy, congenital heart defects, intestinal dysbiosis, allergic diseases, anemia and some chronic diseases.Discussion. The main principle for the formation of a full protective immunity from pertussis infection is the mandatory administration of a full primary course of vaccination against pertussis, with the completion of three vaccinations at the age of 10-12 months and mandatory control over the timely receipt of a booster dose no later than the child reaches two years of age. In addition, it is necessary to introduce additional booster doses of pertussis vaccine at the age of 6-7 years, 12-14 years, vaccination of adults every 10 years, as well as consider the introduction of vaccination of expectant mothers in each pregnancy at 27-36 weeks, vaccination for medical personnel and employees who provide child care services.
- 4 November 2020
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 97 (5) , 492-502
Open AccessCauses and consequences of delayed vaccination against pertussis infection in the Russian Federation
Introduction. One of the reasons for the increase of pertussis in the Russian Federation on the background of the widespread coverage of prophylactic vaccinations of more than 95% is a large number of unreasonable medical recusals and parental refusals and, as a result, untimely prophylactic vaccinations against pertussis infection.Materials and methods. We analyzed 5101 emergency notifications for pertussis in children under 17 years of age in Moscow in 2012-2017 and 300 child development histories for children under 14 years of age in two clinics in Moscow. A сase-сontrol study was conducted to assess the relationship between pertussis and the presence of deviations in the immunization schedule.Results. It was found that the level of timely immunization against pertussis did not exceed 5%. Medical (20%) and parental refusals (45%) prevail among the reasons for delayed vaccination. In the structure of medical exemption, the main causes are perinatal encephalopathy, congenital heart defects, intestinal dysbiosis, allergic diseases, anemia and some chronic diseases.Discussion. The main principle for the formation of a full protective immunity from pertussis infection is the mandatory administration of a full primary course of vaccination against pertussis, with the completion of three vaccinations at the age of 10-12 months and mandatory control over the timely receipt of a booster dose no later than the child reaches two years of age. In addition, it is necessary to introduce additional booster doses of pertussis vaccine at the age of 6-7 years, 12-14 years, vaccination of adults every 10 years, as well as consider the introduction of vaccination of expectant mothers in each pregnancy at 27-36 weeks, vaccination for medical personnel and employees who provide child care services.
- Open Access
- 4 November 2019
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 18 (5) , 85-91
The Problem of Timeliness of Young Children Vaccination and Ways to Solve It
Проблема своевременности вакцинации детей раннего возраста и пути ее решения
- 4 November 2019
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 18 (5) , 85-91
Open AccessThe Problem of Timeliness of Young Children Vaccination and Ways to Solve It
Проблема своевременности вакцинации детей раннего возраста и пути ее решения